α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss

Topic: Brain proteins, microglia and lab models

Synaptic and neuronal loss are major neuropathological characteristics of Parkinson's disease. Misfolded protein aggregates in the form of Lewy bodies, comprised mainly of α-synuclein (αSyn), are associated with disease progression, and have also been linked to other neurodegenerative diseases, including Lewy body dementia, Alzheimer's disease, and frontotemporal dementia. However, the effects of αSyn and its mechanism of synaptic damage remain incompletely understood. Here, we show that αSyn oligomers induce Ca 2+ -dependent release of glutamate from astrocytes obtained from male and female mice, and that mice overexpressing αSyn manifest increased tonic release of glutamate in vivo In turn, this extracellular glutamate activates glutamate receptors, including extrasynaptic NMDARs (eNMDARs), on neurons both in culture and in hippocampal slices of αSyn-overexpressing mice. Additionally, in patch-clamp recording from outside-out patches, we found that oligomerized αSyn can directly activate eNMDARs. In organotypic slices, oligomeric αSyn induces eNMDAR-mediated synaptic loss, which can be reversed by the drug NitroSynapsin. When we expose human induced pluripotent stem cell-derived cerebrocortical neurons to αSyn, we find similar effects. Importantly, the improved NMDAR antagonist NitroSynapsin, which selectively inhibits extrasynaptic over physiological synaptic NMDAR activity, protects synapses from oligomeric αSyn-induced damage in our model systems, thus meriting further study for its therapeutic potential. SIGNIFICANCE STATEMENT Loss of synaptic function and ensuing neuronal loss are associated with disease progression in Parkinson's disease (PD), Lewy body dementia (LBD), and other neurodegenerative diseases. However, the mechanism of synaptic damage remains incompletely understood. α-Synuclein (αSyn) misfolds in PD/LBD, forming Lewy bodies and contributing to disease pathogenesis. Here, we found that misfolded/oligomeric αSyn releases excessive astrocytic glutamate, in turn activating neuronal extrasynaptic NMDA receptors (eNMDARs), thereby contributing to synaptic damage. Additionally, αSyn oligomers directly activate eNMDARs, further contributing to damage. While the FDA-approved drug memantine has been reported to offer some benefit in PD/LBD (Hershey and Coleman-Jackson, 2019), we find that the improved eNMDAR antagonist NitroSynapsin ameliorates αSyn-induced synaptic spine loss, providing potential disease-modifying intervention in PD/LBD.

Key findings

• Misfolded protein aggregates in the form of Lewy bodies, comprised mainly of α-synuclein (αSyn), are associated with disease progression, and have also been linked to other neurodegenerative diseases, including Lewy body dementia, Alzheimer's disease, and frontotemporal dementia.
• Additionally, in patch-clamp recording from outside-out patches, we found that oligomerized αSyn can directly activate eNMDARs.
• SIGNIFICANCE STATEMENT Loss of synaptic function and ensuing neuronal loss are associated with disease progression in Parkinson's disease (PD), Lewy body dementia (LBD), and other neurodegenerative diseases.
• Here, we found that misfolded/oligomeric αSyn releases excessive astrocytic glutamate, in turn activating neuronal extrasynaptic NMDA receptors (eNMDARs), thereby contributing to synaptic damage.

Study details

• Evidence strengthLow

Read the original

• DOI: 10.1523/jneurosci.1871-20.2020
• PubMed: 33483428
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

@article{trudler2021-33483428,
  author  = {Trudler, D. and Sanz-Blasco, S. and Eisele, Y. S. and Ghatak, S. and Bodhinathan, K. and Akhtar, M. W. and Lynch, W. P. and Piña-Crespo, J. C. and others},
  title   = {{α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss}},
  journal = {The Journal of neuroscience : the official journal of the Society for Neuroscience},
  year    = {2021},
  doi     = {10.1523/jneurosci.1871-20.2020},
  pmid    = {33483428},
  url     = {https://doi.org/10.1523/jneurosci.1871-20.2020}
}

Related studies in Disease mechanisms

• Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway The Journal of neuroscience : the official journal of the Society for Neuroscience · 2007-03-01 · usefulness score 36/100
• Soluble Aβ oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors The Journal of neuroscience : the official journal of the Society for Neuroscience · 2011-05-01 · usefulness score 36/100
• β-Amyloid Peptides Induce Mitochondrial Dysfunction and Oxidative Stress in Astrocytes and Death of Neurons through Activation of NADPH Oxidase Journal of Neuroscience · 2004-01-14 · usefulness score 40/100
• Loss of excitatory inputs and decreased tonic and evoked activity of locus coeruleus neurons in aged P301S mice Neurobiology of Disease · 2025-03-22 · usefulness score 39/100
• Impaired glutamate transport in a mouse model of tau pathology in astrocytes The Journal of neuroscience : the official journal of the Society for Neuroscience · 2006-01-01 · usefulness score 36/100
• α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B Nature neuroscience · 2017-09-25 · usefulness score 41/100

Also tagged “mice”

1,150 studies in the library carry the topic tag “mice”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,150 tagged studies.

• AutoDock and AutoDockTools for Protein-Ligand Docking: Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1(BACE1) as a Case Study Methods in molecular biology (Clifton, N.J.) · 2017-01-01 · usefulness score 47/100 · Risk genes beyond APOE
• A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model The Journal of clinical investigation · 2004-05-01 · usefulness score 50/100 · Risk genes beyond APOE
• The alpha secretase ADAM10: A metalloprotease with multiple functions in the brain Progress in neurobiology · 2015-10-29 · usefulness score 46/100 · Risk genes beyond APOE

Similar studies

• Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death 2011 · Lewy body dementia
• Impact of hippocampal α‐synuclein oligomers on cognitive trajectory in patients with dementia with Lewy bodies 2025 · Lewy body dementia
• A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration 2010 · Disease mechanisms
• Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies 2007 · Disease mechanisms
• Alpha-synuclein stimulation of astrocytes: Potential role for neuroinflammation and neuroprotection 2010 · Inflammation and the immune system
• α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies 2017 · Inflammation and the immune system

More on Disease mechanisms

• A review that covers this ground Synapse loss in dementias Journal of neuroscience research · 2010-08-01 · usefulness score 36/100
• Newest in this subject Aβ42 oligomers disrupt calcium homeostasis via Piezo1 and induce neurotoxicity in differentiated SH-SY5Y cells Research Square · 2026-10-29 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Neuronal Hyperactivity Induces Tau Phosphorylation Selectively in Excitatory Pyramidal Neurons Which Contributes to GluA2 Regulation bioRxiv · 2026-10-28 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Disease mechanisms →